Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last A$0.92 AUD
Change Today 0.00 / 0.00%
Volume 3.5M
SIP On Other Exchanges
As of 1:10 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

sigma pharmaceuticals ltd (SIP) Snapshot

Previous Close
Day High
Day Low
52 Week High
03/24/15 - A$1.01
52 Week Low
03/27/14 - A$0.64
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield

Related News

No related news articles were found.

sigma pharmaceuticals ltd (SIP) Related Businessweek News

No Related Businessweek News Found

sigma pharmaceuticals ltd (SIP) Details

Sigma Pharmaceuticals Limited engages in the wholesale and distribution of pharmaceutical products to hospitals and retail pharmacies in Australia. It operates approximately 300 pharmacies under the Amcal name; and 150 pharmacies under the Guardian name. The company also offers health management services, including professional advice; and tailored products in the areas of heart health, bones and joints, diabetes, and respiration under the Amcal Max name. In addition, it manages and promotes a range of over the counter private and exclusive label products made available to brand member customers, as well as a generic range of private label products under the Pharmacy Care range. Sigma Pharmaceuticals Limited was founded in 1912 and is headquartered in Rowville, Australia.

Founded in 1912

sigma pharmaceuticals ltd (SIP) Top Compensated Officers

Chief Executive Officer, Managing Director an...
Total Annual Compensation: A$1.7M
Chief Financial Officer
Total Annual Compensation: A$602.8K
Chief Operating Officer
Total Annual Compensation: A$680.9K
Compensation as of Fiscal Year 2015.

sigma pharmaceuticals ltd (SIP) Key Developments

Sigma Pharmaceuticals Ltd. Announces Final and Special Dividend for the Year Ended January 31, 2015, Payable on 16 April 2015; Omits to Pay an Interim Dividend During the 2015 Financial Year

Sigma Pharmaceuticals Ltd. resolved to pay final dividend of 2.0 cents per share and special dividend of 1.0 cent per share, both fully franked, to be paid on 16 April 2015. The ex-dividend date is 31 March 2015. The record date is 2 April 2015. The company also announced that, due to insufficient franking credits resulted in 2014 Directors Report, it will not pay an interim dividend during the 2015 financial year.

Sigma Pharmaceuticals Ltd. Reports Audited Consolidated Earnings Results for the Year Ended January 31, 2015

Sigma Pharmaceuticals Ltd. reported audited consolidated earnings results for the year ended January 31, 2015. For the year, the company reported sales revenue of AUD 3,142,126,000 against AUD 2,973,466,000 a year ago. Profit before financing costs was AUD 78,055,000 against AUD 70,315,000 a year ago. Profit before income tax was AUD 75,590,000 against AUD 68,333,000 a year ago. Profit was AUD 52,772,000 against AUD 53,536,000 a year ago. Basic and diluted earnings per share for profit attributable to the ordinary equity holders of the company were 4.8 cents per share against 4.8 cents per share a year ago. Net cash inflow from operating activities was AUD 61,314,000 against AUD 79,647,000 a year ago. Payments for property, plant and equipment, software and intangibles were AUD 10,232,000 against AUD 7,293,000 a year ago. Underlying EBIT was AUD 78,356,000 against AUD 71,160,000 a year ago. Underlying NPAT was AUD 53,080,000 against AUD 51,048,000 a year ago.

Sigma Pharmaceuticals Ltd., 2015 Earnings Call, Mar 19, 2015

Sigma Pharmaceuticals Ltd., 2015 Earnings Call, Mar 19, 2015


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIP:AU A$0.92 AUD 0.00

SIP Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for SIP.
View Industry Companies

Industry Analysis


Industry Average

Valuation SIP Industry Range
Price/Earnings 19.2x
Price/Sales 0.3x
Price/Book 1.8x
Price/Cash Flow 16.8x
TEV/Sales 0.3x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA PHARMACEUTICALS LTD, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at